LifeVantage Corporation (the “Company”, “we”, “our” or “us”) previously scheduled its fiscal year 2017 Annual Meeting of Shareholders for February 22, 2017 (the “FY 2017 Annual Meeting”) as publicly disclosed on December 14, 2016 on the Company’s Current Report on Form 8-K. The Company has rescheduled the FY 2017 Annual Meeting for February 16, 2017. In our proxy statement relating to our fiscal year 2016 annual meeting of shareholders (the “FY 2016 Annual Meeting”), we disclosed the deadlines by which shareholders must notify us of any proposals to be included in the proxy materials distributed by us for the FY 2017 Annual Meeting.

Because the expected date of the FY 2017 Annual Meeting has been established for February 16, 2017, which is more than 30 days from the anniversary of our FY 2016 Annual Meeting, we have set a new deadline for the receipt of shareholder proposals submitted in accordance with Rule 14a-8 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), for inclusion in our proxy materials for the FY 2017 Annual Meeting. In order to be considered timely, such proposals must be received by our Corporate Secretary no later than December 27, 2016, which is a reasonable time before we begin to print and mail our proxy materials. Proposals must be sent to the Company’s principal executive office c/o Corporate Secretary, 9785 S. Monroe Street, Suite 300, Sandy, Utah 84070, and must also comply with Rule 14a-8 of the Exchange Act regarding the inclusion of shareholder proposals in company-sponsored proxy materials.

Shareholders also have the right under our bylaws to directly nominate director candidates and make other shareholder proposals by following specified procedures. For a shareholder proposal for the FY 2017 Annual Meeting that is not intended to be included in our proxy statement under Rule 14a-8, including director nominations, the shareholder must (1) provide the information required by our bylaws and (2) give timely notice to our Corporate Secretary at the address above in accordance with our bylaws, which, in general, require that the notice be received by our Corporate Secretary by no later than December 27, 2016, which is the tenth day following the date on which public announcement of the date of the annual meeting is first made.

>

About LIFEVANTAGE CORPORATION (NASDAQ:LFVN)

LifeVantage Corporation is a science-based network marketing company. The Company focuses on helping people achieve their health, wellness and financial independence goals. The Company provides products and a financially rewarding direct sales business opportunity to customers and independent distributors seeking a healthy lifestyle and financial freedom. It sells its products to preferred customers, retail customers and independent distributors located in the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand and the United Kingdom. The Company engages in the identification, research, development and distribution of advanced nutraceutical dietary supplements and skin care products, including Protandim, its scientifically-validated dietary supplement; LifeVantage TrueScience, its line of anti-aging skin care products; Canine Health; Axio, its energy drink mixes, and PhysIQ.

LIFEVANTAGE CORPORATION (NASDAQ:LFVN) Recent Trading Information

LIFEVANTAGE CORPORATION (NASDAQ:LFVN) closed its last trading session up +0.03 at 8.53 with 60,167 shares trading hands.